Skip to main content

Table 2 Multivariate analysis: association between patiens characteristics and early progression

From: Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?

 

p value

Odds ratio (95% CI)

Cerebral metastasis

0.48

3.18 (0.12–81.69)

Pleural effusion

0.66

0.53 (0.33–8.71)

ECOG PS

0.39

2.58 (0.92–22.75)

Serum kyn/trp

0.01

0.01 (0.00–0.41)

Serum quinolic acid

0.81

1.38 (0.09–20.30)